Trial Profile
Docetaxel/5'DFUR or docetaxel for advanced or recurrent gastric cancer as 2nd line chemotherapy
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 May 2017
Price :
$35
*
At a glance
- Drugs Doxifluridine (Primary) ; Docetaxel
- Indications Gastric cancer
- Focus Adverse reactions; Therapeutic Use
- 04 Jan 2007 New trial record.